Complete Remission of Multiple Brain Metastases in a Patient with EGFR-Mutated Non-Small-Cell Lung Cancer Treated with First-Line Osimertinib without Radiotherapy

Figure 1

The patient was diagnosed with T4N1M1c Stage IVB lung adenocarcinoma with EGFR exon 19 deletion mutation presenting as (a) 40 mm wide shadows in the upper lobe of the left lung and (b) multiple bilateral small nodules in the entire lung field.

(a)

(b)